22.03.2017
- The US Food and Drug Administration (FDA) has approved Novartis’ new drug Kisqali (ribociclib) as an initial treatment for postmenopausal women with a type of metastatic breast...
12.01.2017
- French drugmaker Ipsen has signed a definitive agreement to buy the global oncology assets of US-based Merrimack Pharmaceuticals in a deal worth potentially more than $1 billion...
08.09.2016
- Peptides in pharmaceutical development have traveled a rough road. It took a long time for these small proteins to emerge as a basis for new medical products. This has become...
19.05.2016
- Swiss drugmaker Novartis has announced plans to split its Pharmaceutical division into two business units, Novartis Pharmaceutical and Novartis Oncology. The first-mentioned will...
14.04.2016
- With immediate effect, Merck KGaA has appointed Maya Martinez-Davis (46) as global head of oncology for its biopharma business, succeeding Andrew Schiermeier. She will be based in...
24.02.2016
- Austrian biotech firm OncoQR ML has cleared an important hurdle toward producing a vaccine against pancreatic cancer. In a preclinical trial of what it termed “a highly relevant...
17.02.2016
- Germany’s Merck KGaA has signed a new framework agreement with Israel’s Weizmann Institute of Science, extending their partnership for another three years with the option for...
14.01.2016
- French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...
